Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof

a technology of lactoferrin and angiogenin, which is applied in the direction of peptide/protein ingredients, depsipeptides, plant/algae/fungi/lichens ingredients, etc., can solve the problems of poor intestinal absorption, poor bioavailability, and reduced bioavailability, and achieve the effect of effective assimilation of coq-10

Active Publication Date: 2011-09-20
NAIDU LP
View PDF28 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0056]A preferred embodiment is directed to a formulation for decreasing the frequency of migraine attack which includes CoQ-10, angiogenin, at least one metal-transport protein, magnesium and riboflavin.

Problems solved by technology

Reduced bioavailability due to poor intestinal absorption is a major limitation to use CoQ-10 as a health supplement.
Therefore, when administered in the form of an oil solution or some kind of water and / or oil suspension or emulsion, lipophilic compounds usually show a poor bioavailability, which results in low concentration and a long build-up time of the compound in the systemic circulation.
While many patents and different formulations claim increased bioavailability of CoQ-10, the data supporting these claims are often inconclusive.
Despite the continuing efforts to enhance the chemical solubility, the issue of limited intestinal diffusion of CoQ-10 continues to plague its applications as a broad-spectrum health supplement.
r). All of the above clinical conditions are manifested by severe fatigue and lack of ene

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

examples

[0140]Compositions containing CoQ-10, LF and AGN can be prepared either by mixing effective amounts of the all three active ingredients into a formula, as individual components; or by adding an effective dosage of a premix of two or all of the three active ingredients at specific pre-calculated ratios.

example-1

CoQ-10 / LF / AGN Premix Compositions

[0141]

TABLE 1CoQ-10:LF:AGN Premix10:6:1Ingredient10:3:1 Premix20:6:1 PremixPremixCoQ-10100 mg60 mg100 mg60 mg100 mgLF 30 mg18 mg 30 mg18 mg 60 mgAGN 10 mg 6 mg 5 mg 3 mg 10 mgTotal Premix140 mg84 mg135 mg81 mg170 mg

[0142]Appropriate CoQ-10 / LF / AGN premix can be incorporated into a specific formulation, at effective amounts as required. For instance, adding 250 mg of CoQ-10 / LF / AGN premix (10:3:1) to formulations amounts to 178.6 mg of CoQ-10, 53.6 mg of LF, and 17.8 mg of AGN.

example-2

LF / AGN Premix Compositions

[0143]

TABLE 2LF:AGN PremixIngredient3:1 Premix2:1 Premix6:1 PremixLF30 mg18 mg30 mg150 mg60 mgAGN10 mg 6 mg15 mg 75 mg10 mgTotal Premix40 mg24 mg45 mg225 mg70 mg

[0144]Appropriate LF / AGN premix can be incorporated into a specific formulation, at effective amounts as required. For instance, adding 250 mg of LF / AGN premix (6:1) to formulations amounts to 214.3 mg of LF, and 35.7 mg of AGN.

Formulations for Cardiovascular Health

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
weightaaaaaaaaaa
Login to View More

Abstract

Methods of enhancing the bio-availability of coenzyme Q10, and methods of supporting the cardiovascular system to accommodate the increase in cellular energy synthesis as a result of the bio-availability of coenzyme Q10 are described. Compositions which include coenzyme Q10, lactoferrin and / or angiogenin are described for use in the related methods, for multi-functional health applications.

Description

RELATED APPLICATIONS[0001]This application claims priority to U.S. Provisional Application No. 60 / 795,871, filed Apr. 28, 2006 which is incorporated herein by reference.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention relates to methods of enhancing the bio-availability of coenzyme Q10, and supporting the cardiovascular system, and a composition including coenzyme Q10, lactoferrin and / or angiogenin for use in the described methods, for multi-functional health applications.[0004]2. Description of the Related Art[0005]Coenzyme Q10 (CoQ-10) is a fundamental molecule for production of cellular energy in most living organisms. It is a fat-soluble quinone (chemical nomenclature: 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone, CAS registry no. 303-98-0), structurally similar to vitamin K and known by the names ubiquinone, ubidecarenone, neuquinone, and vitamin-Q.[0006]Although found in all human cells, CoQ-10 occurs at relatively elevated concentr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): A61K38/40C07K14/79C07K14/515
CPCA61K31/12A61K38/40A61K33/06A61K31/525A61K45/06A61K38/47A61K38/1891C12Y302/01017A61K36/185A61K36/90A61K36/889A61K2300/00A61P1/00A61P1/16A61P11/00A61P15/00A61P21/00A61P25/00A61P29/00
Inventor NAIDU, A. SATYANARAYANNAIDU, A. G. TEZUSNAIDU, A. G. SREUS
Owner NAIDU LP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com